GlassScriptPhysician profile
Elizabeth Morrow
NPI 1346924735
$3,655.60
in general payments reported to CMS, 2019-2025
22 companies · $613 in 2025
The $613 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $556 · 2024: $2,486 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,655.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,471.12 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $274.28 | 2024 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.36 | 2023-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $228.18 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $197.67 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Merck Sharp & Dohme LLC | $178.57 | 2023-2024 | Verquvo |
| Medtronic, INC. | $151.22 | 2025 | Endurant Iis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.91 | 2023-2024 | Jardiance |
| Scpharmaceuticals INC. | $129.68 | 2023-2025 | |
| W. L. Gore & Associates, INC. | $98.45 | 2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Shockwave Medical, INC | $90.23 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $81.83 | 2023-2024 | Repatha |
| Abiomed | $63.45 | 2024 | Impella |
| Novartis Pharmaceuticals Corporation | $47.16 | 2024-2025 | |
| Stryker Corporation | $43.79 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $41.65 | 2025 | Extended Holter, Ecc Solutions |
| Heartflow, INC. | $35.75 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $31.53 | 2024 | Farxiga |
| Lexicon Pharmaceuticals, INC. | $29.60 | 2023-2024 | Inpefa |
| Atricure, INC. | $24.39 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Janssen Pharmaceuticals, INC | $23.80 | 2024 | Xarelto |
| Lemaitre Vascular, INC. | $18.98 | 2025 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Morrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.